BNTX BioNTech SE
$85.88▼ -1.13%
Healthcare
Other
Volume 219.8K
Avg Volume (10D) 1.30M
Key Metrics & Fundamentals
Market Cap
$21.57B
P/E Ratio
–
Div Yield
0.00%
52W Range
79.52 - 124.00
% vs 50 MA
-11.69%
% vs 200 MA
-10.85%
RSI-14
36.2
MACD Histogram
-0.3600
Beta (1Y vs SPY)
0.97
Free Cash Flow
-$44.90M
Gross Rev
$105.60M
Gross Profit
$8.60M
EBITDA
-$606.40M
COGS
$97.00M
Operating Exp
$947.30M
Operating Income
-$938.70M
EBIT
-$938.70M
Pretax Income
-$858.70M
Net Income
-$820.80M
EPS (Diluted)
-3.24
Price & Volume History
Loading chart…
Recent News
The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings
24/7 Wall St. · Oct 27, 2026 9:28 AM ET
Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady
24/7 Wall St. · Oct 26, 2026 9:14 AM ET
BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer
GlobeNewswire · Oct 26, 2026 5:00 AM ET
BioNTech (BNTX) Expanded Its Oncology Pipeline, Is It Still 25% Below Fair Value?
Simply Wall St. · Oct 25, 2026 10:16 AM ET
BioNTech (BNTX) Reworks Phase 3 Breast Cancer Trial Around New Combination Approach
Simply Wall St. · Oct 25, 2026 8:14 AM ET
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
GlobeNewswire · Oct 25, 2026 3:30 AM ET
Moderna’s Cancer-Vaccine Leak Spurs Panic Selling. Wall Street Wanted a Cure.
Barrons.com · Oct 23, 2026 4:10 PM ET
Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip
24/7 Wall St. · Oct 23, 2026 9:17 AM ET
BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer
GlobeNewswire · Oct 22, 2026 6:45 AM ET
BioNTech (BNTX) Stock May Be Fully Valued Despite Fresh Oncology Data Preview
Simply Wall St. · Oct 22, 2026 12:32 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BNTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.